Cleared Traditional

K812829 - COATEST ANTITHROMBIN
(FDA 510(k) Clearance)

Dec 1981
Decision
83d
Days
Class 2
Risk

K812829 is an FDA 510(k) clearance for the COATEST ANTITHROMBIN. This device is classified as a Antithrombin Iii Quantitation (Class II - Special Controls, product code JBQ).

Submitted by Kabivitrum, Inc. (Walker, US). The FDA issued a Cleared decision on December 30, 1981, 83 days after receiving the submission on October 8, 1981.

This device falls under the Hematology FDA review panel. Regulated under 21 CFR 864.7060.

Submission Details

510(k) Number K812829 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 08, 1981
Decision Date December 30, 1981
Days to Decision 83 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary

Device Classification

Product Code JBQ — Antithrombin Iii Quantitation
Device Class Class II - Special Controls
CFR Regulation 21 CFR 864.7060

Similar Devices — JBQ Antithrombin Iii Quantitation

All 55
INNOVANCE Antithrombin
K242952 · Siemens Healthcare Diagnostic Products GmbH · Mar 2025
INNOVANCE ANTITHROMBIN WITH MODELS OPFH03, OPFHO5
K081769 · Siemens Healthcare Diagnostics · May 2009
HEMOSIL ANTITHROMBIN
K070301 · Instrumentation Laboratory CO · Feb 2007
HEMOSIL LIQUID ANTITHROMBIN
K062431 · Instrumentation Laboratory CO · Sep 2006
BIOPHEN ANTITHROMBIN 2.5, REFERENCE # 221102; BIOPHEN ANTITHROMBIN 5, REFERENCE # 221105
K043007 · Hyphen Biomed · Nov 2005
HEMOSIL LIQUID ANTITHROMBIN XL
K033775 · Instrumentation Laboratory CO · Jan 2004